Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Pilot Study: Intensive Education in a Residential Camp Setting for Families of Young Children With Type 1 Diabetes (TotCamp)

21. juni 2017 opdateret af: University of Texas Southwestern Medical Center
18 preschool aged children and their families will attend structured, multidisciplinary, family-centered intensive education sessions over a 3-day weekend in a residential camp setting to address the unique challenges of managing type 1 diabetes mellitus in young children. A second 'booster' session, will be conducted 6 months later.

Studieoversigt

Status

Afsluttet

Betingelser

Intervention / Behandling

Detaljeret beskrivelse

We propose to deliver a structured multidisciplinary family-centered intervention over a 3-day weekend, with a second similar "booster" session 6 months later. The intervention will be based at our regional diabetes camp, Camp Sweeney. The proposed camp encounters aim to provide:

  • An opportunity for intensive education beyond that achievable in a single class, and without the unfavorable impacts of multiple weekday classes on family and work time.
  • Varied educational modalities including didactic sessions, practical demonstrations and role playing.
  • Close observation of each child throughout the day and night by experienced diabetes counselors and medical staff to identify and help correct maladaptive family behaviors.
  • A safe environment where parents can participate in group therapy sessions without child care worries.
  • An opportunity for age-appropriate child-centered educational and therapeutic activities.
  • An opportunity for families to form mutually-supportive friendships.
  • Fun weekends away where the parents have help caring for their diabetic children.

We will conduct this pilot study, which will enroll 18 preschool children age 3-5.5 years, with the goal of obtaining preliminary results for 15 subjects.

The primary outcome, to be determined approximately one month before and after each of the two camp sessions, is improvement in Hemoglobin A1c (HbA1c). This outcome will be compared with that of historical controls.

Exploratory Hypotheses:

Compared with pretreatment baseline and historical controls, subjects attending two 3-day sessions at a family diabetes camp will improve:

  • HbA1c 3 months after the first camp session
  • Hypoglycemia frequency, as measured by continuous glucose monitoring
  • Medical system utilization, as measured by telephone call frequency and also by emergency room visits and hospitalizations
  • Behavioral/QoL assessments, including the parents of young children version of the hypoglycemia fear survey (HFS-P-YC), the Behavioral Pediatrics Feeding Assessment Scale (BPFAS), and the general and diabetes modules of the PedsQL.
  • Diabetes knowledge, assessed by questionnaire
  • Development of friendships between subject families, assessed by questionnaire

Undersøgelsestype

Interventionel

Tilmelding (Faktiske)

18

Fase

  • Ikke anvendelig

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

2 år til 5 år (Barn)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Alle

Beskrivelse

Inclusion Criteria:

  • Age 3-5.5 years old (+/- 2 months) at the date of first camp session they are eligible to join.
  • Child and Parents fluent in either English or Spanish.
  • Type 1 diabetes mellitus diagnosed for at least 10 months previous to date of first camp they are eligible to join.
  • Taking insulin
  • Custodial parent or guardian (preferable both parents or guardians) willing to attend both session of camp and the activities scheduled for them.
  • Parent or guardian must sign consent before any study procedures are performed.

Exclusion Criteria:

  • Neonatal diabetes (diagnosis in the first 3 months of life) or documented MODY; i.e., a likely genetic form of diabetes rather than an autoimmune etiology.
  • Post-surgical diabetes (e.g., pancreatectomy for congenital hyperinsulinism). Such patients often cannot secrete glucagon, leading to a particularly severe inability to defend against hypoglycemia.
  • Other severe chronic disease (e.g., cancer, cystic fibrosis) which in the judgment of the investigator is likely to significantly affect glycemic control.
  • Patients cannot be taking systemic corticosteroids at enrollment because of adverse effects on glycemic control, but we will not disqualify subjects who require such therapy during the study. Inhaled or topical corticosteroids are permissible.
  • Patients with hypothyroidism or hyperthyroidism must be clinically euthyroid and have free T4 and TSH within age-appropriate reference ranges at last medically indicated testing. Patients with out of range values may be retested after medication dose adjustment.
  • Developmental delay or behavioral disorder in the patient of sufficient severity, in the judgment of the investigator, to interfere with group activities.
  • Medical or psychiatric disorder in a parent of sufficient severity, in the judgment of the investigator, to interfere with group activities.
  • Celiac disease is not an exclusion criterion.

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Støttende pleje
  • Tildeling: N/A
  • Interventionel model: Enkelt gruppeopgave
  • Maskning: Ingen (Åben etiket)

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Andet: Intensive Education
Attendance of 2 intensive education sessions
Adfærdsmæssigt: Intensive Education
Participants will attend a 3 day family-centered, multidisciplinary, intensive education session at our regional diabetes camp, Camp Sweeney. A second 'booster' session will be conducted 6 months later.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Change in Hemoglobin A1c one month pre-camp to one month post-camp Session 1
Tidsramme: One month pre-camp, one month post-camp
As compared to historical controls
One month pre-camp, one month post-camp
Change in Hemoglobin A1c one month pre-camp to one month post-camp Session 2
Tidsramme: One month pre-camp, one month post-camp
As compared to historical controls
One month pre-camp, one month post-camp

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Change in Hypoglycemia frequency one month pre-camp to one month post-camp Session 1
Tidsramme: One month pre-camp, one month post-camp
As measured by continuous glucose monitoring, and quantitated as area under the curve for blood glucoses <70 mg/dL.
One month pre-camp, one month post-camp
Change in Hypoglycemia frequency one month pre-camp to one month post-camp Session 2
Tidsramme: One month pre-camp, one month post-camp
As measured by continuous glucose monitoring, and quantitated as area under the curve for blood glucoses <70 mg/dL.
One month pre-camp, one month post-camp
Medical system utilization ( emergency room visits, hospitalizations related to T1DM)
Tidsramme: Duration of participation in study, expected to be 10 months
Composite measure. As compared to historical controls.
Duration of participation in study, expected to be 10 months
Change in PedsQL Family Impact Module one month pre-camp to one month post-camp Session 1
Tidsramme: One month pre-camp, one month post-camp
Parent report
One month pre-camp, one month post-camp
Change in PedsQL Family Impact Module one month pre-camp to one month post-camp Session 2
Tidsramme: One month pre-camp, one month post-camp
Parent report
One month pre-camp, one month post-camp
Change in PedsQL Pediatric Quality of Life Inventory one month pre-camp to one month post-camp Session 1
Tidsramme: One month pre-camp, one month post-camp
Parent report for Toddlers, Parent report for Young Children, Young Child Report
One month pre-camp, one month post-camp
Change in PedsQL Pediatric Quality of Life Inventory one month pre-camp to one month post-camp Session 2
Tidsramme: One month pre-camp, one month post-camp
Parent report for Toddlers, Parent report for Young Children, Young Child Report
One month pre-camp, one month post-camp
Change in PedsQL Diabetes Module one month pre-camp to one month post-camp Session 1
Tidsramme: One month pre-camp, one month post-camp
Parent report for Toddlers, Parent report for Young Children, Young Child Report
One month pre-camp, one month post-camp
Change in PedsQL Diabetes Module one month pre-camp to one month post-camp Session 2
Tidsramme: One month pre-camp, one month post-camp
Parent report for Toddlers, Parent report for Young Children, Young Child Report
One month pre-camp, one month post-camp
Change in Hypoglycemia Fear Survey one month pre-camp to one month post-camp Session 1
Tidsramme: One month pre-camp, one month post-camp
Parents of young children version
One month pre-camp, one month post-camp
Change in Hypoglycemia Fear Survey one month pre-camp to one month post-camp Session 2
Tidsramme: One month pre-camp, one month post-camp
Parents of young children version
One month pre-camp, one month post-camp
Change in Behavioral Pediatrics Feeding Assessment one month pre-camp to one month post-camp Session 1
Tidsramme: One month pre-camp, one month post-camp
Behavior section
One month pre-camp, one month post-camp
Change in Behavioral Pediatrics Feeding Assessment one month pre-camp to one month post-camp Session 2
Tidsramme: One month pre-camp, one month post-camp
Behavior section
One month pre-camp, one month post-camp

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Sponsor

University of Texas Southwestern Medical Center

Efterforskere

  • Ledende efterforsker: Perrin White, MD, UT Southwestern Medical Center

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart

1. juli 2014

Primær færdiggørelse (Faktiske)

1. august 2016

Studieafslutning (Faktiske)

1. januar 2017

Datoer for studieregistrering

Først indsendt

10. marts 2015

Først indsendt, der opfyldte QC-kriterier

28. april 2015

Først opslået (Skøn)

4. maj 2015

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

23. juni 2017

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

21. juni 2017

Sidst verificeret

1. juni 2017

Mere information

Begreber relateret til denne undersøgelse

Nøgleord

Yderligere relevante MeSH-vilkår

Andre undersøgelses-id-numre

  • STU 042014-061

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

INGEN

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Kliniske forsøg med Type 1 diabetes mellitus

Kliniske forsøg med Intensive Education

Søg i lignende forsøg

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

CROs by country

CROs in United States

Betingelser

Sjældne sygdomme

Narkotikainterventioner

Kosttilskud

Sponsor / samarbejdspartnere

Placeringer

Abonner